72-kDa Gelatinase (Gelatinase A): Structure, Activation, Regulation, and Substrate Specificity

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Chemistry

• Identifiers
  DOI 10.1016/B978-012545090-4/50005-7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The AP-1 site and MMP gene regulation: what is all the fuss about?

  1997cited by this paper
• Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5.

  1997cited by this paper
• Interaction of CED-4 with CED-3 and CED-9: A Molecular Framework for Cell Death

  1997cited by this paper
• Release of gelatinase A during platelet activation mediates aggregation

  1997cited by this paper
• Tumor angiogenesis: functional similarities with tumor invasion.

  1997cited by this paper
• Matrix Metalloproteinases MMP2 and MMP9 Are Produced in Early Stages of Kidney Morphogenesis but Only MMP9 Is Required for Renal Organogenesis In Vitro

  1997cited by this paper
• Urokinase Plasminogen Activator and Gelatinases Are Associated with Membrane Vesicles Shed by Human HT1080 Fibrosarcoma Cells*

  1997cited by this paper
• Specific, High Affinity Binding of Tissue Inhibitor of Metalloproteinases-4 (TIMP-4) to the COOH-terminal Hemopexin-like Domain of Human Gelatinase A

  1997cited by this paper
• Control of type IV collagenase activity by components of the urokinase–plasmin system: a regulatory mechanism with cell‐bound reactants

  1997cited by this paper
• T cell adhesion to endothelial cells and extracellular matrix is modulated upon transendothelial cell migration.

  1997cited by this paper
• Matrix Metalloproteinase 2 (Gelatinase A) Regulates Glomerular Mesangial Cell Proliferation and Differentiation*

  1996cited by this paper
• Laminin-5 and hemidesmosomes: role of the alpha 3 chain subunit in hemidesmosome stability and assembly.

  1996cited by this paper
• Matrix Metalloproteinase Expression During Mouse Peri‐implantation Development

  1996cited by this paper
• Prognostic significance of circulating matrix metalloproteinase-2 to tissue inhibitor of metalloproteinases-2 ratio in recurrence of urothelial cancer after complete resection.

  1996cited by this paper
• The serpin PAI-1 inhibits cell migration by blocking integrin αvβ3 binding to vitronectin

  1996cited by this paper
• Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas

  1996cited by this paper
• Endothelial-cell-stimulating angiogenesis factor (ESAF) activates progelatinase A (72 kDa type IV collagenase), prostromelysin 1 and procollagenase and reactivates their complexes with tissue inhibitors of metalloproteinases: a role for ESAF in non-inflammatory angiogenesis.

  1996cited by this paper
• Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3

  1996cited by this paper
• Gelatinase A activity directly modulates melanoma cell adhesion and spreading.

  1995cited by this paper
• Autolytic activation of recombinant human 72 kilodalton type IV collagenase.

  1995cited by this paper
• The C-terminal Region of Membrane Type Matrix Metalloproteinase Is a Functional Transmembrane Domain Required for Pro-gelatinase A Activation (*)

  1995cited by this paper
• Analysis of Expression of Matrix Metalloproteinases-2 and −9 in Hypopharyngeal Squamous Cell Carcinoma by in Situ Hybridization

  1995cited by this paper
• Degradation of vitronectin by matrix metalloproteinases‐1, ‐2, ‐3, ‐7 and ‐9

  1995cited by this paper
• gelatinase A/TIMP‐2 imbalance in lymph‐node‐positive breast carcinomas, as measured by RT‐PCR

  1995cited by this paper
• Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase

  1995cited by this paper
• Occurrence and distribution of matrix metalloproteinase-2-immunoreactivity in human embryonic tissues.

  1995cited by this paper
• Gelatinase A possesses a β‐secretase‐like activity in cleaving the amyloid protein precursor of Alzheimer's disease

  1995cited by this paper
• Thrombin Induces the Activation of Progelatinase A in Vascular Endothelial Cells

  1995cited by this paper
• Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate.

  1995cited by this paper
• Expression and in‐situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer

  1995cited by this paper
• Furin-dependent intracellular activation of the human stromelysin-3 zymogen

  1995cited by this paper
• Matrix Metalloproteinase-2 Is an Interstitial Collagenase

  1995cited by this paper
• Immunohistochemical localization of matrix metallloproteinase 2 and its specific inhibitor timp‐2 in neoplastic tissues with monclonal antibodies

  1994cited by this paper
• Gelatinase activity during wound healing

  1994cited by this paper
• Calcium signalling in platelets and other nonexcitable cells.

  1994cited by this paper
• A matrix metalloproteinase expressed on the surface of invasive tumour cells

  1994cited by this paper
• Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples.

  1994cited by this paper
• A new nomenclature for the laminins.

  1994cited by this paper
• Extracellular Matrix‐Degrading Proteinases in the Nervous System

  1994cited by this paper
• Proteolysis of Aβ Peptide from Alzheimer Disease Brain by Gelatinase A

  1994cited by this paper
• Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane.

  1994cited by this paper
• Gelatinase A expression and localization in human breast cancers. An in situ hybridization study and immunohistochemical detection using confocal microscopy

  1994cited by this paper
• Increased expression of the 72-kd type IV collagenase in prostatic adenocarcinoma. Demonstration by immunohistochemistry and in situ hybridization.

  1994cited by this paper
• Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line.

  1994cited by this paper
• Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A.

  1994cited by this paper
• Developmental regulation of the expression of 72 and 92 kd type IV collagenases in human trophoblasts: a possible mechanism for control of trophoblast invasion.

  1994cited by this paper
• Regulation of Matrix Metalloproteinase Activity a

  1994cited by this paper
• The gelatin-binding site of human 72 kDa type IV collagenase (gelatinase A).

  1994cited by this paper
• The rabbit gene for 92-kDa matrix metalloproteinase. Role of AP1 and AP2 in cell type-specific transcription.

  1994cited by this paper
• Domain-specific activation of neuronal migration and neurite outgrowth-promoting activities of laminin.

  1994cited by this paper
• Matrix Metalloproteinase Gene Expression a

  1994cited by this paper
• Human 92 kDa type IV collagenase: functional analysis of fibronectin and carboxyl-end domains.

  1993cited by this paper
• A large cell-adhesive scatter factor secreted by human gastric carcinoma cells.

  1993cited by this paper
• The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A.

  1993cited by this paper
• Stability analysis of latent and active 72-kDa type IV collagenase: the role of tissue inhibitor of metalloproteinases-2 (TIMP-2).

  1993cited by this paper
• Binding and localization of M(r) 72,000 matrix metalloproteinase at cell surface invadopodia.

  1993cited by this paper
• Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors.

  1993cited by this paper
• Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro

  1993cited by this paper
• Signal transduction from the extracellular matrix

  1993cited by this paper
• Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer.

  1993cited by this paper
• Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma.

  1993cited by this paper
• Activity of type IV collagenases in benign and malignant breast disease.

  1993cited by this paper
• Matrix metalloproteinases: a review.

  1993cited by this paper
• Tumor cell interactions with the extracellular matrix during invasion and metastasis.

  1993cited by this paper
• Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin.

  1993cited by this paper
• Cellular activation of the 72 kDa type IV procollagenase/TIMP-2 complex.

  1993cited by this paper
• Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion.

  1993cited by this paper
• The matrix‐degrading metalloproteinases

  1992cited by this paper
• Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization.

  1992cited by this paper
• Large inhibitor of metalloproteinases (LIMP) contains tissue inhibitor of metalloproteinases (TIMP)-2 bound to 72,000-M(r) progelatinase.

  1992cited by this paper
• Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas.

  1992cited by this paper
• Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases.

  1992cited by this paper
• Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions.

  1992cited by this paper
• Higher-order complex formation between the 72-kilodalton type IV collagenase and tissue inhibitor of metalloproteinases-2.

  1992cited by this paper
• The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases.

  1992cited by this paper
• Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin.

  1992cited by this paper
• Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia.

  1992cited by this paper
• Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes.

  1991cited by this paper
• Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression.

  1991cited by this paper
• The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72-kDa progelatinase is a metalloproteinase inhibitor.

  1991cited by this paper
• Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma.

  1991cited by this paper
• Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP).

  1991cited by this paper
• Human 92- and 72-kilodalton type IV collagenases are elastases.

  1991cited by this paper
• Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.

  1991cited by this paper
• Identification of a basal promoter for the human Mr 72,000 type IV collagenase gene and enhanced expression in a highly metastatic cell line.

  1991cited by this paper
• Differential susceptibility of type X collagen to cleavage by two mammalian interstitial collagenases and 72-kDa type IV collagenase.

  1990cited by this paper
• Structure of the human type IV collagenase gene.

  1990cited by this paper
• Bimodal relationship between invasion of the amniotic membrane and plasminogen activator activity

  1990cited by this paper
• Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases.

  1990cited by this paper
• Studies on the ability of 65-kDa and 92-kDa tumor cell gelatinases to degrade type IV collagen.

  1990cited by this paper
• Adenovirus E1A represses protease gene expression and inhibits metastasis of human tumor cells.

  1990cited by this paper
• Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines.

  1990cited by this paper
• Cleavage specificity of human skin type IV collagenase (gelatinase). Identification of cleavage sites in type I gelatin, with confirmation using synthetic peptides.

  1990cited by this paper
• Aggregin: a platelet ADP receptor that mediates activation

  1990cited by this paper
• Identification of an inhibitor of neovascularization from cartilage.

  1990cited by this paper
• Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro

  1990cited by this paper
• Elevated levels of the α5β1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells

  1990cited by this paper
• Cleavage of collagen type X by human synovial collagenase and neutrophil elastase.

  1989cited by this paper
• Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase.

  1989cited by this paper
• Molecular mechanisms of platelet activation.

  1989cited by this paper

• Gut Microbial Dysbiosis Induced Exacerbations Influence the Progression of Colorectal Cancer

  2024cites this paper
• Clinicopathologic and Prognostic Significance of Gelatinase A in Tunisian Colorectal Cancer: A Case-Control Study

  2017cites this paper
• Impact of silk biomaterial structure on proteolysis.

  2015cites this paper
• Type I Collagen Accelerates the Spreading of Lens Epithelial Cells through the Expression and Activation of Matrix Metalloproteinases

  2014influential citation
• Antitumor Effect of Honey and Squirting Cucumber Fruit Juice Mixture on Glioblastoma Cells in Vitro

  2011cites this paper
• Kinetic and docking studies of inhibitors targeting the catalytic zinc in MA clan enzymes

  2011cites this paper
• Investigation of the Relationship between Endometrial MMP Activities and Sex Hormones in Mature Bitches

  2011cites this paper
• Emerging Ideas: Matrix Metalloproteinase-2 in Muscle Atrophy

  2010cites this paper
• Effect of Simvastatin on the Migration and Invasion of U-373-MG Cells

  2010cites this paper
• In vitro Inhibition of Human MMP-2 Collagenolytic and Gelatinolytic Activity by Neutralizing Monoclonal Antibodies

  2010cites this paper
• Chapter 2 Expression of Matrix Metalloproteinases-2 and-9 in Intestinal Tissue of Patients with Inflammatory Bowel Disease ( IBD ) Short title : gelatinases in IBD

  2009cites this paper
• ANÁLISE IN VITRO DA EXPRESSÃO DE PROTEÍNAS DA MATRIZ EXTRACELULAR (MEC) E DE METALOPROTEINASES DA MATRIZ (MMPs) EM CÉLULAS-TRONCO DE POLPA DENTÁRIA HUMANA

  2008cites this paper
• Matrix metalloproteinase‐2 expression and promoter/enhancer activity in skeletal muscle atrophy

  2008cites this paper
• TNF- α stimulates activation of pro-MMP2 in human skin through NF- κ B mediated induction of MT1-MMP

  2008cites this paper
• Proteolytic Degradation of VE-Cadherin Alters the Blood-Retinal Barrier in Diabetes

  2007cites this paper
• Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)‐2 and ‐9 in Crohn's disease

  2007cites this paper
• CHAPTER 3 Eradication of Helicobacter pylori infection favourably a ects altered gastric mucosal MMP-9 levels

  2007cites this paper
• Ornithine decarboxylase overexpression enhances ERK and p38 phosphorylation and matrix metalloproteinase‐2 expression

  2007cites this paper
• Molecular biology and functions of epilysin (MMP-28)

  2007cites this paper
• Eradication of Helicobacter pylori Infection Favourably Affects Altered Gastric Mucosal MMP‐9 Levels

  2007cites this paper
• Matrix metalloproteinases in development and disease.

  2006cites this paper
• Vegf is Likely a Key Factor in the Link between Inflammation and Angiogenesis in Psoriasis: Results of an Immunohistochemical Study

  2006cites this paper
• The role of MMP-2 and MMP-9 in the development of squamous cell carcinoma

  2006cites this paper
• On-column activation of bovine recombinant metalloproteinase 20.

  2006cites this paper
• Temporal expression of protein mediators during PGF2alpha-induced luteolysis in sheep

  2006cites this paper
• Upregulation of Matrix Metalloproteinases following Nerve Injury Is Not Mediated by Mast Cell Activation

  2005cites this paper
• Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood–retinal barrier

  2005cites this paper
• Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases.

  2005influential citation
• Ornithine decarboxylase, mitogen-activated protein kinase and matrix metalloproteinase-2 expressions in human colon tumors.

  2005cites this paper
• Extracellular Superoxide Dismutase and Matrix Metalloproteinases in Pulmonary Fibrosis

  2005cites this paper
• Basic and Clinical Aspects of Mucosal Inflammation and Healing in Crohn's Disease

  2005cites this paper
• Turmoil in the Cardiac Myocyte: Acute Intracellular Activation of Matrix Metalloproteinases

  2005cites this paper
• Reversibility of Liver Fibrosis

  2005cites this paper
• Chapter 6 Expression of matrix metalloproteinases ( M M P )-2 and M M P-9 in intestinal tissue of patients with inflammatory bowel diseases ( IBD ) Short title : MMPs in IBD

  2005cites this paper
• Infliximab influences the expression of matrix metalloproteinase ( M M P )-2 and-9 in Crohn ' s disease Short title : Infliximab and MMPs in CD

  2005cites this paper
• Three small integrin‐binding ligand N‐linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinases

  2004cites this paper
• The Role of Nitric Oxide in Heart Failure

  2004cites this paper
• Modular Autonomy, Ligand Specificity, and Functional Cooperativity of the Three In-tandem Fibronectin Type II Repeats from Human Matrix Metalloproteinase 2*

  2004cites this paper
• Immunohistochemical study of characteristics of bile duct dysplasia evaluated on the basis of expression of metastasis/invasion-related factors and p53.

  2004cites this paper
• Myocardial Remodeling in Viral Heart Disease: Possible Interactions Between Inflammatory Mediators and MMP-TIMP System

  2004cites this paper
• Characterization of gelatinases in bronchoalveolar lavage fluid and gelatinases produced by alveolar macrophages isolated from healthy calves.

  2004cites this paper
• Matrix Metalloproteinases and Their Clinical Applications in Orthopaedics

  2004cites this paper
• Peroxynitrite in Myocardial Ischemia-Reperfusion Injury

  2004cites this paper
• Expression of matrix metalloproteinases, inhibitor, and acid phosphatase in muscles of immobilized hindlimbs of rats

  2003cites this paper
• Matrix metalloproteinase inhibitors attenuate endotoxemia induced cardiac dysfunction: A potential role for MMP-9

  2003cites this paper
• Effect of sulfated GAGs on the expression and activation of MMP‐2 and MMP‐9 in corneal and dermal explant cultures

  2003cites this paper
• Biochemistry of Hypertrophy and Heart Failure

  2003cites this paper
• Inhibitory effect of procyanidin oligomer from elm cortex on the matrix metalloproteinases and proteases of periodontopathogens.

  2003cites this paper
• Peptide Ligands for the Fibronectin Type II Modules of Matrix Metalloproteinase 2 (MMP-2)*

  2003cites this paper
• Differential expression of matrix metalloproteinases in monkey eyes with experimental glaucoma or optic nerve transection.

  2003cites this paper
• Matrix Metalloproteinases and Myocardial Remodeling in Heart Failure

  2003cites this paper
• Stem Cells Expressing Matrix Metalloproteinase-13 mRNA Appear during Regression Reversal of Hepatic Cirrhosis

  2003cites this paper
• Solubilization of type I collagen from fish muscle connective tissue by matrix metalloproteinase‐9 at chilled temperature

  2003cites this paper
• MMPs and TIMPs—An historical perspective

  2002cites this paper
• Cloning and characterization of cDNA for carp matrix metalloproteinase 9

  2002cites this paper
• Matrix metalloproteinases and tissue inhibitors of metalloproteinases in hamster aortic atherosclerosis: correlation with in-situ zymography.

  2002cites this paper
• Matrix metalloproteinases mediate the dismantling of mesenchymal structures in the tadpole tail during thyroid hormone‐induced tail resorption

  2002cites this paper
• Matri xMetalloproteinase sMediat eth eDismantlin gof Mesenchyma lStructure si nth eTadpol eTai lDuring Thyroi dHormone-Induce dTai lResorption

  2002cites this paper
• MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology.

  2002cites this paper
• Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers

  2002cites this paper
• Penta-O-galloyl-beta-D-glucose inhibits the invasion of mouse melanoma by suppressing metalloproteinase-9 through down-regulation of activator protein-1.

  2002cites this paper
• Expression, activation, and regulation of matrix metalloproteinase 2 (MMP-2) in the bovine corpus luteum

  2002cites this paper
• The Col-1 Module of Human Matrix Metalloproteinase-2 (MMP-2): Structural/Functional Relatedness between Gelatin-Binding Fibronectin Type II Modules and Lysine-Binding Kringle Domains

  2002cites this paper
• MMPs and TIMPs

  2001cites this paper
• Dynamic change of cells expressing MMP-2 mRNA and MT1-MMP mRNA in the recovery from liver fibrosis in the rat.

  2001cites this paper
• Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices.

  2001cites this paper
• Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes

  2001cites this paper
• Interleukin‐10 Inhibition of Gelatinases in Fetal Membranes: Therapeutic Implications in Preterm Premature Rupture of Membranes

  2001influential citation
• Proteolysis of AA amyloid fibril proteins by matrix metalloproteinases-1, -2, and -3.

  2001cites this paper
• Pharmacological characteristics of solid‐phase von Willebrand factor in human platelets

  2001cites this paper
• Gelatin-binding Region of Human Matrix Metalloproteinase-2

  2001cites this paper
• Requirement for Pbx1 in skeletal patterning and programming chondrocyte proliferation and differentiation.

  2001cites this paper
• Biology and Regulation of the Matrix Metalloproteinases

  2001cites this paper
• Requirement for Pbx 1 in skeletal patterning and programming chondrocyte proliferation and differentiation

  2001cites this paper
• Activation of matrix metalloproteinase-2 by a novel oral spirochetal species Treponema lecithinolyticum.

  2001cites this paper
• EFFECT OF HYALURONAN ON MMP EXPRESSION AND ACTIVATION

  2001cites this paper
• Coordinate expression of matrix-degrading proteinases and their activators and inhibitors in bovine skeletal muscle.

  2001cites this paper
• TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP.

  2001cites this paper
• Distribution pattern of matrix metalloproteinases 1, 2, 3, and 9, tissue inhibitors of matrix metalloproteinases 1 and 2, and α2-macroglobulin in cases of generalized AA- and AL amyloidosis

  2000cites this paper
• Temporospatial distribution of matrix metalloproteinase and tissue inhibitors of matrix metalloproteinases during murine secondary palate morphogenesis

  2000cites this paper
• Proteases and Protease Inhibitors in Tissue Repair

  2000cites this paper
• Prostaglandin E2-dependent production of latent matrix metalloproteinase-9 in cultures of human fetal membranes

  2000cites this paper
• Pseudomonas Aeruginosa Virulence Factors Delay Airway Epithelial Wound Repair by Altering the Actin Cytoskeleton and Inducing Overactivation of Epithelial Matrix Metalloproteinase–2

  2000cites this paper
• Temporospatial expression of tissue inhibitors of matrix metalloproteinases-1, -2 and -3 during development, growth and aging of the mouse skeleton

  2000cites this paper
• Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling.

  2000cites this paper
• La Mmp-9 : une métalloprotéase à facettes multiples.

  2000cites this paper
• Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion.

  2000cites this paper
• Basement membrane alterations in psoriasis are accompanied by epidermal overexpression of MMP-2 and its inhibitor TIMP-2.

  2000cites this paper
• Amniochorion Gelatinase‐Gelatinase Inhibitor Imbalance In Vitro: A Possible Infectious Pathway to Rupture

  2000cites this paper
• Messenger RNA for membrane-type 2 matrix metalloproteinase, MT2-MMP, is expressed in human placenta of first trimester.

  2000cites this paper
• Evidence of in vivo differential bioavailability of the active forms of matrix metalloproteinases 9 and 2 in parturition, spontaneous rupture of membranes, and intra-amniotic infection.

  2000cites this paper
• Curcuminoids Inhibit the Angiogenic Response Stimulated by Fibroblast Growth Factor-2, Including Expression of Matrix Metalloproteinase Gelatinase B*

  2000cites this paper
• Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines.

  2000cites this paper
• Programmed cell death (apoptosis) as a possible pathway to metalloproteinase activation and fetal membrane degradation in premature rupture of membranes.

  2000cites this paper
• Matricellular proteins as modulators of cell-matrix interactions: adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2.

  2000cites this paper
• Rapid Release of Matrix Metalloproteinase (MMP)-2 by Thrombin in the Rat Aorta: Modulation by Protein Tyrosine Kinase/Phosphatase

  1999influential citation
• The second type II module from human matrix metalloproteinase 2: structure, function and dynamics

  1999cites this paper
• Developmental differences in the expression and modulation of extracellular matrix proteases and inhibitors in mouse skin fibroblasts

  1999cites this paper